iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Shares Up 0.7% – Still a Buy?

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)’s stock price rose 0.7% during mid-day trading on Monday . The stock traded as high as $23.14 and last traded at $22.91. Approximately 61,518 shares traded hands during mid-day trading, an increase of 106% from the average daily volume of 29,814 shares. The stock had previously closed at $22.74.

iShares Genomics Immunology and Healthcare ETF Trading Up 0.7 %

The stock’s 50 day moving average price is $22.77 and its two-hundred day moving average price is $23.80. The firm has a market capitalization of $134.02 million, a price-to-earnings ratio of 2.29 and a beta of 1.14.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iShares Genomics Immunology and Healthcare ETF stock. Avior Wealth Management LLC purchased a new position in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 9,500 shares of the company’s stock, valued at approximately $234,000. Avior Wealth Management LLC owned approximately 0.16% of iShares Genomics Immunology and Healthcare ETF at the end of the most recent reporting period.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.